Melbourne, Australia – Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is today presenting at the ASX Emerging Growth conference in London. 

More than 150 institutional fund managers are confirmed for the event.  Starpharma is one of 18 companies participating in this invitation only event, and one of only two healthcare companies. Mesoblast is the other.  

The London event is part of the ASX Spotlight Series in which Starpharma participated last year presenting to institutional investors in both Hong Kong (October 2010) and Singapore (May 2010). 

The presentation by CEO Dr Jackie Fairley is attached, and covers:

• Starpharma’s unique and valuable platform technology based on dendrimers – a nanotechnology that is being applied to pharmaceuticals, drug delivery and agricultural applications.
• Lead product VivaGel^®, a topical microbicide under development for the prevention of sexually transmitted infections including genital herpes, human papillomavirus and HIV.  It is also under development as a condom coating licensed to Reckitt Benckiser.
• Progress of the phase 2 clinical program for the study of VivaGel^® for both the treatment and prevention of recurrence of bacterial vaginosis (BV), the most common vaginal infection worldwide.  The treatment market alone for BV is in excess of US$300M currently with the prevention market likely to be substantially larger again.
• Other important applications of dendrimers including drug delivery and agrochemicals.
• Recent expansion of the agrochemical program following the receipt of a $250,000 grant from the Victorian Government.
• A successful business model of partnering with market-leading companies to maximise the value of Starpharma’s technology.  Partners include Reckitt Benckiser, Lilly, Siemens Healthcare, GSK, Elanco, and EMD Merck.

The ASX conference involves emerging Australian companies with a market capitalisation of up to AU$2B.  Details of the London event are available at: http://www.asx.com.au/smalltomidcaps/london/

Download ASX Announcement & Presentation: SPL presents at ASX Emerging Growth Conference ( pdf file, 2MB)